Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr;148(4):1003-1004.
doi: 10.1007/s00432-021-03801-5. Epub 2021 Sep 16.

Response to letter to the editor regarding C Franzese et al. "Metastasis-directed stereotactic body radiation therapy in the management of oligometastatic head and neck cancer"

Affiliations

Response to letter to the editor regarding C Franzese et al. "Metastasis-directed stereotactic body radiation therapy in the management of oligometastatic head and neck cancer"

Ciro Franzese et al. J Cancer Res Clin Oncol. 2022 Apr.

Abstract

Authors' response to the letter directed to C Franzese et al. on the role of radiotherapy in oligometastatic head neck cancer.

PubMed Disclaimer

Conflict of interest statement

None.

References

    1. Franzese C, Ingargiola R, Tomatis S et al (2020) Metastatic salivary gland carcinoma: a role for stereotactic body radiation therapy? A study of AIRO-Head and Neck working group. Oral Dis. 10.1111/odi.13755 - PubMed
    1. Franzese C, Badalamenti M, Teriaca A et al (2021) Metastasis-directed stereotactic body radiation therapy in the management of oligometastatic head and neck cancer. J Cancer Res Clin Oncol 147(5):1307–1313 - PMC - PubMed
    1. Iqbal MS, Kovarik J, Patil R, Kelly C (2021a) Supporting “Metastasis-directed stereotactic body radiation therapy in the management of oligometastatic head and neck cancer.” J Cancer Res Clin Oncol. 10.1007/s00432-021-03754-9 (Epub ahead of print. PMID: 34351481) - PMC - PubMed
    1. Iqbal MS, West N, Richmond N et al (2021b) A systematic review and practical considerations of stereotactic body radiotherapy in the treatment of head and neck cancer. Br J Radiol 94(1117):20200332 - PMC - PubMed

LinkOut - more resources